Drug recall · July 30, 2025
Budesonide Inhalation Suspension recall
Why: Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)
- Lots / codes
Batch # 4IA0505, Exp 09/31/2026
- Quantity
- 13,680 ampoules
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- June 30, 2025 · Voluntary: Firm initiated
- Classified
- July 22, 2025
- Reported
- July 30, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Budesonide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.